No quarterly revenue total was found in Black Hawk Acquisition Corporation's SEC filings.
Black Hawk Acquisition Corporation (BKHA) files with the SEC under industry code 2836, Biological Products, (No Diagnostic Substances).
Revenue
—
Net income
$1.07M
+596.1% vs year-ago quarter
Operating cash flow
$-113,451
-5.1% vs year-ago quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
4.15M
+0.0% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BKHA (Nasdaq), BKHAR (Nasdaq), BKHAU (Nasdaq)
- Fiscal year ends
- November 30
- Headquarters
- Danville, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2000775
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Aug 31, 2026 |
Q2 FY2026 May 31, 2026 |
Q1 FY2026 Feb 28, 2026 |
Q4 FY2025 Nov 30, 2025 |
Q3 FY2025 Aug 31, 2025 |
|---|---|---|---|---|---|
| Operating income | -$138,210 | -$109,215 | -$54,189 | -$217,878 | -$341,265 |
| Net income | $1.1M | $88,929 | $139,805 | -$3,765 | $154,401 |
| Operating cash flow | -$113,451 | -$236,637 | -$109,502 | -$100,479 | -$107,914 |
| Total assets | $26.0M | $25.4M | $24.8M | $23.9M | $23.3M |
| Total liabilities | $4.8M | $5.2M | $4.7M | $3.9M | $3.4M |
| Stockholders' equity | -$4.7M | -$5.1M | -$4.5M | -$3.8M | -$3.3M |
| Cash and investments | $0 | $0 | $0 | $0 | $0 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Oct 23, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 13, 2026 | Oct 13, 2026 |
| 10-Q | Quarterly report | Oct 6, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 24, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Other events
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Aug 26, 2026 | Aug 21, 2026 |
All 116 Black Hawk Acquisition Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.